CBS 2019
CBSMD教育中心
中 文

DAPT Duration

Abstract

Recommended Article

P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Dual antiplatelet therapy: how, how long, and in which patients? Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial

GuidelineOctober 2017, Volume 10, Issue 10

JOURNAL:Circ Cardiovasc Qual Outcomes. Article Link

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Jneid H, Addison D, Bhatt DL et al. Keywords: AHA Scientific Statements; ST-elevation myocardial infarction; acute myocardial infarction; non–ST-elevation myocardial infarction; performance measures; quality indicators; quality measures